Related Experiment Video
Updated: Feb 17, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
High-Confidence Protein-Ligand Complex Modeling by NMR-Guided Docking Enables Early Hit Optimization
Andrew Proudfoot1, Dirksen E Bussiere1, Andreas Lingel1,2
1Global Discovery Chemistry, Novartis Institutes for BioMedical Research , 5300 Chiron Way, Emeryville, California 94608, United States.
This study introduces a novel NMR-guided docking protocol for structure-based drug design. The method successfully generates high-quality protein-ligand complex models, enabling prospective optimization of drug fragments.
Area of Science:
- Biochemistry
- Structural Biology
- Drug Discovery
Background:
- Structure-based drug design relies on protein-ligand complex characterization, typically via X-ray crystallography.
- Crystallography success is limited for dynamic proteins and weak binders, hindering drug optimization.
- This limitation restricts chemical scaffold diversity and exploration in drug discovery.
Purpose of the Study:
- To develop a robust NMR restraint-guided docking protocol for generating high-quality protein-ligand complex models.
- To overcome limitations of X-ray crystallography in drug discovery for challenging targets.
- To enable prospective optimization of fragment hits into more potent binders.
Main Methods:
- Utilized a novel NMR restraint-guided docking protocol.
- Combined highly methyl-labeled proteins with experimentally determined intermolecular distances.
- Generated comprehensive protein-ligand distance restraints to drive docking and determine ligand conformation.
Main Results:
- Successfully generated high-quality models of protein-ligand complexes.
- Demonstrated the utility and performance of the NMR-guided docking protocol.
- Achieved prospective optimization of crystallographically intractable fragment hits into more potent binders.
Conclusions:
- The NMR restraint-guided docking protocol is a powerful tool for structure-based drug design.
- This method overcomes limitations associated with X-ray crystallography for difficult targets.
- Enables enhanced exploration of chemical space and optimization of novel drug candidates.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
The Equilibrium Binding Constant and Binding Strength
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Protein-protein Interfaces
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...